series-a
Stage
1
Investors
About
Inimmune is a clinical-stage biotech company developing novel immunotherapies and vaccine adjuvants that harness the innate immune system to treat inflammatory diseases including allergies, cancer, and autoimmune conditions.
Explore Inimmune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.